Skip to content
    GL
    Earnings call· Jun 2026(Q2 FY26)

    GLOBE LIFE INC. GL

    Jul 23, 2026 Source

    Executive summary

    Globe Life Inc. Q2 FY26 — Strong Earnings Growth and Capital Returns

    Globe Life delivered robust Q2 FY26 results, showcasing consistent double-digit operating EPS growth and a strong capital return program, including an increased share repurchase target. While some distribution channels faced headwinds from agent count declines and evolving digital marketing landscapes, management is actively implementing strategies, including AI-driven initiatives, to adapt and drive future growth. The company also made progress on its Bermuda reinsurance subsidiary, aiming for more efficient capital management and ongoing cash flows to the parent.

    Highlights

    5

    • Net income per share increased 20% to $3.65.

    • Net operating income per share grew 10% to $3.61, marking double-digit growth in 8 of the last 9 quarters.

    • Total premium revenue grew 7% year-over-year.

    • Share repurchases totaled $175 million at an average price of $154.28, with full-year guidance raised by $100 million to $670 million-$700 million.

    • Consolidated RBC ratio was 316% at year-end 2025, within the target range of 300%-320%.

    Concerns

    4

    • Net life sales at American Income Life were down 2% due to a 7% decline in average producing agent count.

    • Net health sales at Liberty National were down 15% as emphasis shifted to life business.

    • Net life sales at Direct-to-Consumer were down 15% due to a transition in online search behavior and increased AI utilization.

    • Health policy obligations as a percent of premium were 56.8%, higher than estimates, driven by Medicare supplement claims, Everi loss ratios, and cancer claims at Liberty National.

    Guidance & targets

    41
    CategoryTargetConfidence
    Total premium revenue growth
    6.5% to 7%
    high materiality
    High
    Life premium revenue growth
    2.5% and 3%
    medium materiality
    High
    Life underwriting margin as % of premium
    43% and 45%
    high materiality
    High
    Life underwriting margin as % of premium
    over 50%
    high materiality
    High
    Life underwriting margin as % of premium
    41% to 42%
    high materiality
    High
    Health premium revenue growth
    14% to 16%
    medium materiality
    High
    Health underwriting margin as % of premium
    23% and 27%
    high materiality
    High
    Administrative expenses as % of premiums
    approximately 7.3%
    medium materiality
    High
    American Income Life (AIL) agent count growth
    mid-single-digit growth
    medium materiality
    Medium
    American Income Life (AIL) life sales growth
    mid-single-digit growth
    medium materiality
    Medium
    Liberty National and Family Heritage average producing agent count growth
    low double digits
    medium materiality
    High
    Liberty National net life sales growth
    low double-digit growth
    medium materiality
    High
    Direct-to-Consumer (DTC) net life sales growth
    single-digit decline
    medium materiality
    Medium
    Liberty National net health sales growth
    slightly down
    low materiality
    Medium
    Family Heritage net health sales growth
    low double-digit growth
    medium materiality
    High
    United American net health sales growth
    30% to 35% growth
    medium materiality
    High
    Net investment income growth
    around 4%
    medium materiality
    High
    Required interest growth
    around 4%
    medium materiality
    High
    Excess investment income growth
    approximately 7%
    medium materiality
    High
    Average yield earned on total long-term investments
    approximately 5.5%
    medium materiality
    High
    Earned yield for fixed maturity portfolio
    around 5.31%
    medium materiality
    High
    Investment acquisitions (fixed maturities)
    $550 million to $600 million
    medium materiality
    High
    Investment acquisitions (all asset classes)
    $700 million to $800 million
    medium materiality
    High
    Parent liquid assets
    top end of our target range of $50 million to $60 million
    medium materiality
    High
    Parent return to shareholders
    approximately $350 million to $370 million
    high materiality
    High
    Dividend payments
    approximately $95 million
    medium materiality
    High
    Share repurchases
    $670 million to $700 million
    high materiality
    High
    Consolidated RBC ratio
    within targeted range of 300% to 320%
    high materiality
    High
    Net operating earnings per diluted share
    $15.55 to $15.95
    high materiality
    High
    Remeasurement gains from Q3 assumption updates (total)
    $110 million to $130 million
    high materiality
    High
    Remeasurement gains from Q3 life assumption update
    $90 million to $100 million
    high materiality
    High
    Remeasurement gains from Q3 health assumption update
    $20 million to $30 million
    high materiality
    High
    Life underwriting margin as % of premium
    52% to 53%
    high materiality
    High
    Health underwriting margin as % of premium
    29% to 32%
    high materiality
    High
    Normalized Life underwriting margin as % of premium
    between 41% and 42%
    high materiality
    High
    United American premium growth
    25% to 35%
    medium materiality
    High
    United American health margin as % of premium
    approximately 7%
    medium materiality
    High
    United American health margin as % of premium (ex-Everi)
    8% to 9%
    medium materiality
    High
    Normalized EPS growth
    between 9% and 10%
    high materiality
    High
    3-year compound annual growth rate of normalized EPS
    approximately 11%
    high materiality
    High
    Everi sales
    approximately $50 million
    low materiality
    High

    Segment performance

    5
    SegmentRevenueYoYQoQMargin
    American Income Life
    Net life sales declined primarily due to a decrease in agent count, though sequential growth in agent count was observed in Q2 following compensation adjustments.
    Life premiums: $466 millionLife premiums growth: 5% YoYLife underwriting margin: $214 millionLife underwriting margin growth: 4% YoYNet life sales: $95 millionNet life sales growth: -2% YoYAverage producing agent count: 11,391Average producing agent count growth: -7% YoYAverage producing agent count sequential growth: 3% QoQ
    		————
    Liberty National
    Strong life sales and agent count growth, but net health sales declined as emphasis shifted to life business. Changes are being implemented to place additional emphasis on health sales.
    Life premiums: $101 millionLife premiums growth: 3% YoYLife underwriting margin: $37 millionLife underwriting margin growth: 10% YoYNet life sales: $26 millionNet life sales growth: 6% YoYNet health sales: $7 millionNet health sales growth: -15% YoYAverage producing agent count: 4,194Average producing agent count growth: 8% YoY
    		————
    Family Heritage
    Performance solidified by ongoing emphasis on developing agency middle management, positioning for sustainable growth.
    Health premiums: $126 millionHealth premiums growth: 9% YoYHealth underwriting margin: $45 millionHealth underwriting margin growth: 10% YoYNet health sales: $31 millionNet health sales growth: 4% YoYAverage producing agent count: 1,608Average producing agent count growth: 7% YoY
    		————
    Direct-to-Consumer (DTC)
    In a transition period due to a shift in online consumer search behavior and increased AI utilization, impacting paid search volume. Initiatives are underway to adapt to these changes.
    Life premiums: $244 millionLife premiums growth: -1% YoYLife underwriting margin: $76 millionLife underwriting margin growth: 10% YoYNet life sales: $27 millionNet life sales growth: -15% YoY
    		————
    United American
    Strong sales in Medicare Supplement business. Health underwriting margin declined due to group business, including Everi, and higher claims experience. Everi is a start-up that has not yet reached target margins.
    Health premiums: $211 millionHealth premiums growth: 29% YoYHealth underwriting margin: $11 millionHealth underwriting margin change: -$1 million YoYNet health sales: $28 millionNet health sales growth: 10% YoYHealth margin as % of premium (ex-Everi): approximately 9% in Q2
    		————

    Operational metrics

    35
    Net operating income per share
    $3.61up 10% YoY
    Q2 FY26

    Double-digit net operating income per share growth in 8 of the last 9 quarters.

    Net income per share
    $3.65up 20% YoY
    Q2 FY26
    Return on equity (GAAP)
    18.4%
    YTD June 30
    Return on equity (ex-AOCI)
    14.3%
    YTD June 30
    Book value per share (ex-AOCI)
    $100.04up 11% YoY
    June 30
    Total premium revenue growth
    7%YoY
    Q2 FY26
    Life underwriting margin as % of premium
    42%up from 41% YoY
    Q2 FY26
    Health underwriting margin as % of premium
    23%down from 26% YoY
    Q2 FY26
    Administrative expenses as % of premium
    7%
    Q2 FY26
    Excess investment income
    $38 millionup 10% YoY
    Q2 FY26

    Defined as net investment income less only required interest.

    Average invested assets growth
    2%YoY
    Q2 FY26
    Required interest growth
    3%YoY
    Q2 FY26

    Slightly lower than 4% growth in average policy liabilities.

    Average yield on total long-term invested assets
    5.51%
    Q2 FY26

    Includes fixed maturity, commercial mortgage loans, and other long-term non-fixed maturity investments.

    Fixed maturity investments
    $19.3 billion
    Q2 FY26
    Investment grade fixed maturities
    $18.8 billion
    Q2 FY26

    Out of $19.3 billion total fixed maturities.

    Net underlying loss position (fixed maturities)
    $1.4 billion
    Q2 FY26

    Due to current market rates being higher than book yield on holdings; relates to bonds with maturities beyond 10 years.

    BBB bonds as % of fixed maturity portfolio
    41%down from 44% YoY
    Q2 FY26

    Lowest level since 2003.

    Below investment-grade bonds as % of total fixed securities
    2.7%consistent with YE 2025
    Q2 FY26
    Total exposure to BBB and below investment-grade as % of equity (ex-AOCI)
    Lowest level in over 25 years
    Q2 FY26
    Share repurchases executed
    1.1 million shares
    Q2 FY26
    Cost of share repurchases
    $175 million
    Q2 FY26
    Average share price for repurchases
    $154.28
    Q2 FY26
    Shareholder dividend payments
    $25 million
    Q2 FY26
    Total capital returned to shareholders
    $200 million
    Q2 FY26

    Includes share repurchases and dividend payments.

    Term loan principal balance
    Increased from $250 million to $450 million
    Q2 FY26

    Increase of $200 million; proceeds to be used for general corporate purposes, including reducing commercial paper balances and increasing share repurchases.

    Term loan maturity date
    June 2029
    Q2 FY26

    Extended from prior maturity date.

    Credit facility maturity date
    June 2031
    Q2 FY26

    Extended from prior maturity date.

    Parent liquid assets
    $110 million
    End of Q2 FY26
    Consolidated RBC ratio (US subsidiaries)
    316%
    End of 2025

    Target range is 300% to 320%.

    Excess capital above minimum target RBC (300%)
    $95 million
    End of 2025
    Life policy obligations as % of premium
    34.3%improved from 36.7% YoY
    Q2 FY26

    Favorable to management's estimates and consistent with continued favorable trends in mortality.

    Health policy obligations as % of premium
    56.8%up from 53.3% YoY
    Q2 FY26

    Higher than estimates, driven by Medicare supplement claims, Everi loss ratios, and cancer claims at Liberty National.

    Medicare Supplement additional premium from rate increases
    $65 million
    FY26

    Expected to be received throughout 2026, primarily in the last 3 quarters of the year.

    Normalized EPS growth (ex-assumption updates)
    9% to 10%
    FY26

    Midpoint of guidance, removes impact of assumption updates to both 2025 and 2026.

    3-year CAGR of normalized EPS
    11%
    Projected

    At the midpoint of guidance.

    Industry KPIs

    10
    MetricValueDetails
    Capital returns$175 millionUSD
    ROE operating ROE18.4%%
    Catastrophe losses—
    Book value per share$70.18USD
    Net investment income$294 millionUSD
    Retention persistency—
    Net premiums written earned$1.298 billionUSD
    Renewal rate change pricing—
    Statutory regulatory capital316%%
    Prior year reserve development—

    Deals & partnerships

    1
    Every HealthAcquisition of a group health insurance marketer, now included in the United American division.

    Every Health markets group health insurance through brokers. Its higher loss ratios contributed to the health underwriting margin decline in Q2.

    Risks & headwinds

    4
    Decline in average producing agent count at American Income Life.Q2 FY26

    Down 7% YoY to 11,391 agents in Q2.

    Mitigation: Compensation adjustments implemented in Q2 to improve agent recruiting and retention; sequential growth in agent count observed in Q2; pipeline of agents in training is up 8% from Q1.

    Transition in Direct-to-Consumer (DTC) sales due to AI utilization and reduced paid search volume.Q2 FY26 and ongoing

    Net life sales down 15% YoY in Q2.

    Mitigation: Initiatives underway to adapt to changes, position digital content for AI assistants, and explore other online advertising platforms; company will remain disciplined on spend to maintain profitability targets.

    Higher health policy obligations.Q2 FY26

    56.8% of premium in Q2, up from 53.3% YoY.

    Mitigation: Driven by Medicare supplement claims related to prior periods (industry-wide CMS correction), higher loss ratios at Everi (due to adverse fluctuation in high severity claims), and adverse fluctuation in cancer claims at Liberty National; claims experience expected to moderate during the remainder of the year; new premium adjustments for Med Supp policies will reflect higher costs.

    Unrealized loss position in fixed maturity investment portfolio.Q2 FY26

    $1.4 billion net underlying loss.

    Mitigation: Primarily interest rate-driven, relates to bonds with maturities beyond 10 years; company has the intent and ability to hold investments to maturity; conservative investment philosophy and strong underwriting profits.

    What to watch in Q3 FY26

    5

    American Income Life (AIL) Agent Count Growth

    H2 FY26
    Current11,391 (down 7% YoY, up 3% QoQ)
    TargetMid-single-digit growth

    Why it matters

    Agent count growth is a primary precursor to sales growth and crucial for AIL's overall performance and future trajectory.

    During the second half of the year, we expect to see mid-single-digit growth in both agent count and life sales at American Income.

    Q&A highlights

    8

    How will Globe Life adjust its sales and advertising strategy to the evolving AI search environment, and what options are being considered?

    Management noted that AI-generated search is increasing the cost of traditional paid search, leading them to explore other platforms like Instagram and Facebook. They emphasized maintaining profitability targets and adapting digital content to be visible to AI assistants, similar to past transitions in online marketing.

    “what's happening is, is that it's really just bidding up the price for paid search. And so -- as we've discussed before, we're going to be disciplined on our spend and make sure that we maintain our margin, and we're not just going to chase sales that don't meet our profitability targets.”

    asked by Wilma Jackson Burdis · answered by James Darden

    3 min read6 chapters

    Detailed Narrative

    01

    AI Integration and Strategic Benefits

    Globe Life is actively exploring and implementing AI applications across its operations, expecting enterprise-wide benefits beyond administrative cost reductions. These initiatives aim to enhance sales growth by improving distribution efficiency, streamline underwriting processes, and optimize sales support, positioning the company to leverage high-volume business characteristics for future improvements. Management highlighted potential for AI to drive sales growth by helping distribution operate more efficiently and effectively, and to improve underwriting and sales support processes.

    02

    Distribution Channel Performance and Agent Dynamics

    The company observed mixed performance across its exclusive agencies. American Income Life experienced a 2% decline in net life sales due to a 7% drop in agent count, though sequential growth in Q2 and pipeline strength suggest a turnaround in the second half. Liberty National and Family Heritage demonstrated strong agent count growth (8% and 7% respectively) and sales momentum, with Liberty National's life sales up 6% and Family Heritage's health sales up 4%.

    03

    Direct-to-Consumer (DTC) Transition

    The DTC division is navigating a significant shift in online consumer behavior driven by AI utilization, leading to reduced paid search volume and a 15% decline in net life sales. Management is adapting by optimizing digital content for AI assistants and exploring alternative advertising avenues, drawing parallels to the past transition from direct mail to digital marketing. The division continues to support agencies by generating over 1 million leads annually, and has seen improved conversion of shared leads.

    04

    Investment Portfolio and Strategy

    Globe Life maintains a conservative investment philosophy with $22.1 billion in invested assets, primarily fixed maturities. The portfolio has an average rating of A- and a net underlying loss position of $1.4 billion, which the company is not concerned about due to its intent and ability to hold investments to maturity. The allocation to BBB-rated bonds has decreased to 41%, the lowest since 2003, reflecting a focus on higher-rated bonds and a strong position to withstand economic downturns. Only 1% of the portfolio is in senior direct lending and asset-based finance combined, and another 1% in traditional private placements.

    05

    Capital Management and Bermuda Subsidiary

    The company repurchased $175 million in shares during Q2 and increased its full-year repurchase guidance to $670 million-$700 million, leveraging an amended term loan. Progress on the Bermuda subsidiary includes Nebraska's approval of reciprocal jurisdiction, with Indiana approval pending. This initiative aims to efficiently manage profit emergence and provide ongoing annual cash flows to the parent, with initial dividends expected in 2027, structured for ongoing annual cash flows rather than a one-time📎 release.

    06

    Health Underwriting Margin Volatility

    The health underwriting margin was impacted by higher-than-estimated policy obligations, driven by Medicare supplement claims from prior periods, adverse loss ratios at Everi (a group health acquisition), and cancer claims at Liberty National. Management views these as fluctuations, not continuing trends, and expects claims experience to moderate, with new premium adjustments for Med Supp policies reflecting higher costs in the future. Despite these impacts, United American's underwriting dollars are still expected to increase 24% year-over-year for the full year.

    AI-generated summary of the company’s earnings call. Not investment advice.